...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion

Hello BikerMike,

i also have had the shares referred to in my account with CIBC as ZENE and I am patient and note that from time to time Zenith does a private placement with an accreditied investor at around the $2.00 USD mark.

 

It is a pain in the proverbial to have another company "Zenith Capital Corporation" with such a similar name and have so much confusion.

 

I find the speculation of an Alberta company versus  BC company to be a plausible reason for the confusing name being allowed for the recent company ZENI-P.

 

Share
New Message
Please login to post a reply